World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5377)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

143

HTML

2695

Figures (1-3)

389

Tables (1-6)

358

Sum=3585

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

209

Download

744

Sum=953

Publishing Process of This Article

Item

Count

Browse

Download

562

Sum=660

May 14, 2024 (publication date) through Sep 1, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Yin JY, Yang TY, Yang BQ, Hou CX, Li JN, Li Y, Wang Q. FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. World J Gastroenterol 2024; 30(18): 2440-2453 [PMID: 38764767 DOI: 10.3748/wjg.v30.i18.2440]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i18/2440.htm

Number	Citing Articles
1	Sanad Dawod, Kimberly Brown. Non-invasive testing in metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1499013
2	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(672) \| Core Tip(697) \| Full Article(HTML)(1406) \| Full Article with Cover (PDF)-639K(144) \| Audio-785K(10) \| Peer-Review Report-230K(81) \| Answering Reviewers-209K(81) \| Full Article (PDF)-410K(103) \| Full Article (XML)-117K(89) \| Times Cited (0) \| Total Visits (4573) \| Open
3	Shuai Zhang, Hao Liang, Jun Liu, Zhipeng Huang, Xijing Shi, Ye Zhu. The association between inflammatory, metabolic, and hepatic fibrosis-related biomarkers and atrial fibrillation in older patients with metabolic dysfunction-associated steatotic liver disease. BMC Geriatrics 2025; 25(1) doi: 10.1186/s12877-025-06120-3
4	Jianing Shi, Xuan Wu, Jiali Yu, Qingli Zhou. Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1651357
5	Yilong Chen, Shuixiu Bian, Jiamei Le. Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives. Genes 2025; 16(4): 399 doi: 10.3390/genes16040399
6	Emre Hoca, Bilal Cangir, Süleyman Ahbab, Seher İrem Şahin, Ece Çiftçi Öztürk, Ayşe Öznur Urvasızoğlu, Nilsu Kalaycı, İsmail Engin, Hayriye Esra Ataoğlu. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients. Diagnostics 2025; 15(16): 2045 doi: 10.3390/diagnostics15162045